Avoralstat
CAS No. 918407-35-9
Avoralstat ( BCX4161 )
Catalog No. M24967 CAS No. 918407-35-9
Avoralstat is an oral plasma kallikrein (PKK) inhibitor. Which is used for the treatment of hereditary angioedema.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 61 | In Stock |
|
5MG | 102 | In Stock |
|
10MG | 155 | In Stock |
|
25MG | 312 | In Stock |
|
50MG | 475 | In Stock |
|
100MG | 692 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAvoralstat
-
NoteResearch use only, not for human use.
-
Brief DescriptionAvoralstat is an oral plasma kallikrein (PKK) inhibitor. Which is used for the treatment of hereditary angioedema.
-
DescriptionAvoralstat is an oral plasma kallikrein (PKK) inhibitor. Which is used for the treatment of hereditary angioedema.
-
SynonymsBCX4161
-
PathwayOthers
-
TargetOther Targets
-
Recptorplasma kallikrein (PKK)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number918407-35-9
-
Formula Weight513.5
-
Molecular FormulaC28H27N5O5
-
Purity>98% (HPLC)
-
SolubilityDMSO:50 mg/mL (97.36 mM; Need ultrasonic)
-
SMILESCOc(c(C=C)c1)cc(-c2ccc(C(NCC3CC3)=O)nc2C(O)=O)c1C(Nc(cc1)ccc1C(N)=N)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Aygoren-Pursun E, et al. Prophylaxis of hereditary angioedema attacks: A randomized trial of oral plasma kallikrein inhibition with avoralstat. J Allergy Clin Immunol. 2016 Sep;138(3):934-936.e5.
molnova catalog
related products
-
4u8C
4μ8C is a potent and selective IRE1 Rnase inhibitor with IC50 of 76 nM.
-
Vanillylacetone
Vanillylacetone, which is used as a flavor additive in spice oils and in perfumery to introduce spicy aromas, is similar in chemical structure to flavor chemicals such as vanillin and eugenol.
-
3-(2-aminopropyl)phe...
3-(2-aminopropyl)phenol hydrochloride is a compound used as a molecular building block.